Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-03 Sale |
2025-04-04 4:23 pm |
Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer |
79,712 | $5.9494 | $474,239 | 822,623 (Indirect Direct) |
View |
| 2025-02-26 Sale |
2025-02-27 12:39 pm |
Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel |
7,373 | $9.1418 | $67,402 | 79,460 (Direct) |
View |
| 2025-02-24 Sale |
2025-02-25 3:44 pm |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A Director |
10,056 | $9.4534 | $95,063 | 3,813,528 (Indirect Direct) |
View |
| 2025-02-24 Sale |
2025-02-25 3:43 pm |
Vir Biotechnology Inc. | VIR | HANLY ANN M. EVP & Chief Technology Officer |
14,168 | $9.4534 | $133,936 | 117,901 (Direct) |
View |
| 2025-02-24 Sale |
2025-02-25 3:37 pm |
Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer |
1,562 | $9.4534 | $14,766 | 86,627 (Direct) |
View |
| 2025-02-24 Sale |
2025-02-25 3:36 pm |
Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer |
16,122 | $9.4534 | $152,408 | 1,382,335 (Indirect Direct) |
View |
| 2025-02-24 Sale |
2025-02-25 3:34 pm |
Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel |
5,140 | $9.4534 | $48,590 | 156,833 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 7:11 pm |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A Director |
10,964 | $9.8117 | $107,575 | 3,823,584 (Indirect Direct) |
View |
| 2025-02-13 Sale |
2025-02-14 6:41 pm |
Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer |
1,562 | $9.1494 | $14,291 | 28,189 (Direct) |
View |
| 2025-01-08 Sale |
2025-01-08 8:03 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
10,960 | $12.52 | $137,219 | 1,312,391 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 3:35 pm |
Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel |
76 | $8.2201 | $625 | 56,973 (Direct) |
View |
| 2024-11-06 Sale |
2024-11-07 7:20 pm |
Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel |
4,397 | $10.11 | $44,454 | 56,973 (Direct) |
View |
| 2024-11-01 Sale |
2024-11-05 5:51 pm |
Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel |
3,750 | $8.6219 | $32,332 | 61,370 (Direct) |
View |
| 2024-09-09 Sale |
2024-09-10 4:28 pm |
Vir Biotechnology Inc. | VIR | Napolitano Janet Director |
12,190 | $7.7959 | $95,032 | 11,616 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-12 12:21 pm |
Vir Biotechnology Inc. | VIR | Ramasastry Saira Director |
4,000 | $10.95 | $43,789 | 14,619 (Direct) |
View |
| 2024-04-03 Sale |
2024-04-04 4:14 pm |
Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer |
72,995 | $9.4577 | $690,365 | 678,457 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-02 8:58 pm |
Vir Biotechnology Inc. | VIR | HANLY ANN M. EVP & Chief Technology Officer |
2,711 | $10.05 | $27,251 | 132,081 (Indirect Direct) |
View |
| 2024-03-27 Sale |
2024-03-28 12:18 pm |
Vir Biotechnology Inc. | VIR | Lee Sung EVP & Chief Financial Officer |
6,008 | $9.8875 | $59,404 | 100,492 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-22 Option Award |
2025-02-25 3:41 pm |
N/A 2035-02-21 |
Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer |
120,000 | $0 | 195,000 (Direct) |
View |
| 2025-02-22 Option Award |
2025-02-25 3:39 pm |
N/A 2035-02-21 |
Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer |
120,000 | $0 | 195,000 (Direct) |
View |
| 2025-02-22 Option Award |
2025-02-25 3:37 pm |
N/A 2035-02-21 |
Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer |
60,000 | $0 | 86,627 (Direct) |
View |
| 2025-02-22 Option Award |
2025-02-25 3:36 pm |
N/A 2035-02-21 |
Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer |
720,000 | $0 | 1,382,335 (Direct) |
View |
| 2025-02-22 Option Award |
2025-02-25 3:34 pm |
N/A 2035-02-21 |
Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel |
105,000 | $0 | 156,833 (Direct) |
View |
| 2024-11-15 Option Award |
2024-11-18 1:36 pm |
N/A 2034-11-14 |
Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2024-10-23 Other |
2024-10-24 4:26 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A Director |
598,270 | $0 | 4,477,628 (Direct) |
View |
Ownership |
2024-10-03 5:11 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |
Ownership |
2024-10-02 12:09 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Sabatini Brent SVP, Chief Accounting Officer |
0 | $0 | 88,439 (Direct) |
View |
Ownership |
2024-10-02 12:07 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | de Verneuil Vanina EVP and General Counsel |
0 | $0 | 245,120 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-16 4:40 pm |
N/A 2034-07-14 |
Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2024-06-12 Other |
2024-06-12 4:00 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | De Backer Marianne Chief Executive Officer |
53,118 | $0 | 784,693 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 12:18 pm |
2025-05-30 2034-05-29 |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
24,000 | $0 | 49,806 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 12:17 pm |
2025-05-30 2034-05-29 |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A Director |
24,000 | $0 | 3,850,548 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 12:16 pm |
2025-05-30 2034-05-29 |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
24,000 | $0 | 1,339,351 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 12:15 pm |
2025-05-30 2034-05-29 |
Vir Biotechnology Inc. | VIR | Ramasastry Saira Director |
24,000 | $0 | 34,619 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 12:14 pm |
2025-05-30 2034-05-29 |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director |
24,000 | $0 | 13,550,704 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 12:13 pm |
2025-05-30 2034-05-29 |
Vir Biotechnology Inc. | VIR | Napolitano Janet Director |
24,000 | $0 | 39,806 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 12:08 pm |
2025-05-30 2034-05-29 |
Vir Biotechnology Inc. | VIR | MORE ROBERT J Director |
24,000 | $0 | 558,573 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 11:59 am |
2025-05-30 2034-05-29 |
Vir Biotechnology Inc. | VIR | Hatfield Jeffrey S. Director |
24,000 | $0 | 39,806 (Direct) |
View |
Ownership |
2024-06-03 11:57 am |
N/A N/A |
Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 2:43 pm |
N/A 2034-05-28 |
Vir Biotechnology Inc. | VIR | Farid Ramy Director |
32,000 | $0 | 48,000 (Direct) |
View |
Ownership |
2024-05-31 2:42 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Farid Ramy Director |
0 | $0 | 0 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 2:40 pm |
N/A 2034-05-28 |
Vir Biotechnology Inc. | VIR | BISCHOFBERGER NORBERT W Director |
32,000 | $0 | 48,000 (Direct) |
View |
Ownership |
2024-05-31 2:38 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | BISCHOFBERGER NORBERT W Director |
0 | $0 | 0 (Direct) |
View |